In the Lewis rat, acute experimental autoimmune encephalomyelitis (EAE) induced by inoculation with myelin basic protein (MBP) and adjuvants is characterized by tail and hindlimb weakness that resolves spontaneously after several days. In rats with neurological signs of this form of EAE (MBP-EAE) we have previously demonstrated demyelination and nerve conduction block in the proximal peripheral nervous system (PNS) and in the central nervous system (CNS). The present study was performed to assess conduction in the PNS and CNS, after recovery from acute MBP-EAE, using direct recordings from surgically exposed spinal roots and spinal cord dorsal columns. The study revealed that 1-2 weeks after clinical recovery from tail paralysis there was almost complete restoration of conduction in the sacral spinal roots but persistent severe conduction abnormalities in the dorsal columns. Significant restoration of conduction through the dorsal columns occurred over the following 2 weeks. These findings indicate that PNS conduction block due to a demyelinating polyradiculitis is a major cause of the neurological signs of acute MBP-EAE in the Lewis rat. Keywords demyelination; experimental autoimmune encephalomyelitis; Lewis rat; multiple sclerosis; myelin basic protein; neurophysiology; pathophysiology Experimental autoimmune encephalomyelitis (EAE) can be induced in laboratory animals by inoculation with homogenized central nervous system (CNS) tissue, myelin basic protein (MBP), or myelin proteolipid protein (PLP), together with complete Freund's adjuvant (CFA). Histological studies of rabbits and rats with EAE induced by inoculation with whole CNS tissue or with MBP reveal perivascular inflammation and primary demyelination in the CNS and proximal peripheral nervous system (PNS), namely the spinal roots and dorsal root ganglia. 10, 12, 16, 18 In contrast, in EAE induced by inoculation with PLP, inflammation and demyelination are confined to the CNS. Neurophysiological studies have shown that in EAE induced by inoculation with whole CNS tissue, conduction abnormalities consistent with primary demyelination are present in the proximal PNS as well as in the CNS. [8] [9] [10] 13, [15] [16] [17] [18] 21 Similar abnormalities are present in EAE induced by inoculation with MBP (MBP-EAE) or by the passive transfer of MBP-sensitized T cells, 2, 5, 8, 12, 13 whereas conduction abnormalities are restricted to the CNS in EAE induced by inoculation with PLP. 2 We have previously shown that, in the Lewis rat, clinical recovery from hindlimb weakness due to acute MBP-EAE is associated with PNS and CNS remyelination and with
However, that study did not reveal whether the clinical recovery was dependent on restoration of conduction in the PNS. In the present study we directly assessed conduction in the surgically exposed sacral spinal roots to deter-mine whether restoration of conduction in the PNS occurs at the time of clinical recovery from MBP-EAE. Conduction was also assessed in the surgically exposed dorsal columns of the spinal cord. We found that 1-2 weeks after clinical recovery from tail paralysis there was almost complete restoration of conduction in the sacral spinal roots but persistent severe conduction abnormalities in the dorsal columns. Significant restoration of conduction through the dorsal columns occurred over the following 2 weeks.
MATERIALS AND METHODS
Animals. Specific pathogen-free male Lewis rats QC strain) were obtained from the University of Queensland Pinjarra Hills breeding colony and kept 5 to a cage with an unrestricted supply of rat cubes and water. The experiments, performed in accordance with National Health and Medical Research Council of Australia's guidelines for animal experimentation, were approved by the local ethics committee.
Preparation of MBP. MBP was prepared from guinea pig spinal cord (after removal of the spinal roots) by the method of Deibler et al. 4 Its purity was assessed by sodium dodecyl sulphate polyacrylamide gel electrophoresis. 6 Induction of Acute MBP-EAE. MBP in 0.9% saline was emulsified in an equal volume of incomplete Freund ' s adjuvant (Difco) (IFA) containing a sus-pension of 4 mg of killed and dried Mycobacterium butyricum (Difco) per milliliter of IFA. Rats were inoculated with 100 µL of the MBP-containing emulsion into the medial footpad of each hindfoot. The total dose of MBP was 50 µg per rat.
Clinical Assessment. Rats were assessed for tail, hindlimb, and forelimb weakness graded in each region on a scale of 0 (no weakness) to 4 (complete paralysis) from day 7 as previously described.
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Electrophysiological Studies Preparation of Animals. Anaesthesia was induced by the intraperitoneal (IP) injection of ketamine (74 mg/kg) (Mavlab Pty. Ltd., Slacks Creek, Australia), xylazine (9 mg/kg) (Parnell Laboratories, Silverwater, Australia) and atropine (36 µg/kg) (Apex Laboratories, St. Marys, Australia). The rats breathed spontaneously through a tracheal cannula (Intramedic ® polyethylene tubing No. 7445, Becton Dickinson, Parsippany, NJ, USA). To maintain the temperature of the animal at 37°C, a metal box containing circulating water at 42°C was placed under the animal during the laminectomy and during the electrophysiological studies. An IP injection of 8 mL of compound sodium lactate intravenous infusion BP (Hartmann's solution) (Baxter Healthcare Pty. Ltd., Old Toongabbie, Australia) was given at the beginning of each experiment, and 1 mL of Haemaccel (Behringwerke AG, Marburg, Germany) was given IP after the laminectomy had been performed, prior to neurophysiological recordings.
Dorsal Root Entry Zone (DREZ)
Recordings. The rat was mounted on a frame following a T-12-L-5 laminectomy and a pool was formed with raised skin flaps and the dura opened. Paraffin oil was added to the pool created by the raised skin flaps to prevent tissue drying and was maintained at 37°C by a thermostatically controlled infrared lamp. A segment of the left ventral caudal trunk, just distal to its junction with the S-2 ventral primary ramus, was exposed and stimulated in continuity with two 0.25-mm-diameter platinum wire electrodes 3 mm apart. The cathode was proximal to the anode. Stimuli were 0.1-ms square-wave voltage pulses delivered at 0.33 Hz. The stimulating and recording arrangements for these and all other recordings in this study have recently been depicted graphically. 2 If the corneal reflex became absent, the experiment was ceased.
Volume conductor recordings were made over the left S-2 DREZ with a 0.5-mmdiameter silver ball electrode as the active electrode. The reference electrode was a platinum wire placed on the right paravertebral region at the same level as the active electrode. A ground electrode was placed, via a steel supporting pin, on the right ilium. The recording electrodes were connected by shielded leads to FET source followers connected to an oscilloscope (Tektronix 5D10 waveform digitizer, Tektronix Inc., Beaverton, OR) via a preamplifier (1000x gain) (bandwidth 5.3 Hz to 10 kHz). For all recordings, negativity at the active recording electrode resulted in an upward deflection on the oscilloscope. Recordings were photographed with an oscilloscope camera. Conduction velocities were calculated after allowing for the utilization time (0.1 ms). 1 Conduction distance was measured as the length of a piece of thread placed along the conduction pathway from the stimulation site on the ventral caudal trunk to the recording site on the S-2 DREZ.
S-2 Dorsal Root Recordings. The left S-2 dorsal root was identified and lifted so that a small piece of plastic sheeting measuring 2.5 mm by 6 mm could be placed underneath the root. The 0.5-mmdiameter silver ball electrode was placed on the segment of the S-2 dorsal root overlying the plastic sheet (6-10 mm distal to the S-2 DREZ), and the reference electrode was placed on the right paravertebral region at the same level as the active re-cording electrode. The left ventral caudal trunk was stimulated as for the DREZ recordings.
Dorsal Column Recordings. The active recording electrode was a 0.5-mm-diameter silver ball electrode placed on the left dorsal column at the level of the S-4 DREZ. The reference electrode was a 0.2-mm-diameter platinum wire electrode placed on the right paravertebral tissues at the same level as the active recording electrode. Two J-shaped 0.25-mm-diameter stimulating platinum wire electrodes were placed 3 mm apart on the left dorsal column, with the cathode caudal, 0.5 mm from the midline and 17 mm rostral to the active recording electrode. Stimulation was by 0.33-Hz square-wave voltage pulses of 20-µs duration.
S-2 Ventral Root
Recordings. The L-5, L-6, sacral, and coccygeal dorsal roots were cut and the caudal spinal cord was rotated so that the left sacral and coccygeal ventral roots could be identified. The left and right S-3, S-4, and coccygeal ventral roots were cut. The left S-2 ventral root was lifted gently and a small piece of plastic placed beneath its proximal portion as described above for the left S-2 dorsal root. A silver ball electrode was placed on the segment of the left S-2 ventral root lying on the plastic sheeting (12-16 mm distal to the S-2 ventral root exit zone). The reference electrode was placed on the right paravertebral region at the same level as the silver ball electrode. The left ventral caudal trunk was stimulated as described above for the S-2 DREZ recordings. Stimuli were 0.1-ms squarewave pulses delivered at 0.33 Hz.
Statistical Analysis. To compare the recordings from rats after clinical recovery from MBP-EAE with those from rats with neurological signs of MBP-EAE and with those from normal controls, one-way analysis of variance (ANOVA) was used when the data was normally distributed. Where a significant F result was obtained, further post hoc comparisons were performed between groups using a two-tailed t-test. To correct the P value for multiple comparisons, the Bonferroni method was used. The statistical analysis program used was GraphPAD InStat (GraphPAD Software, San Diego CA).
RESULTS

Clinical Findings in Rats Studied
Neurophysiologically. We studied 5 rats aged 12-13 weeks, 1-2 weeks after clinical recovery from tail paralysis and hindlimb weakness due to acute MBP-EAE, and 5 rats aged 15-16 weeks, 4 weeks after clinical recovery. Results from these rats were compared with previously reported data from 23 normal control rats aged 9-13 weeks, and 14 rats aged 11-12 weeks with tail paralysis and (in 11 rats) hindlimb weakness due to acute MBP-EAE.
S-2 Ventral Root
Recordings. The normal S-2 ventral root response evoked by stimulation of the ventral caudal trunk consists of a biphasic wave (positive, negative) ( Fig. 1A ; Table 1 ). In rats with neurological signs of MBP-EAE there is a marked reduction in the mean peakto-peak amplitude of the maximal ventral root compound action potential compared to that in normal controls, and the mean conduction velocity of the peak of the negativity is less than that in normal controls, but not significantly ( Fig. 1B; Table 1 ). In the absence of temporal dispersion, the reduction in the amplitude of the ventral root response indicates a failure of excitation at the stimulation site or conduction block in a high proportion of the efferent fibers between the proximal ventral root and the ventral caudal trunk. The presence of a normal compound muscle action potential elicited by stimulation of the ventral caudal trunk at the same site indicates that conduction block is present in the ventral root. 2 In rats studied 1-2 weeks after clinical recovery the mean peak-to-peak amplitude was significantly increased, compared to the corresponding value in rats with neurological signs of MBP-EAE, and was not significantly different from that in normal controls ( Table 1 ). The mean conduction velocity was intermediate between that in rats with neurological signs and that in normal controls but the differences were not statistically significant. The results in rats studied 4 weeks after clinical recovery were similar to those in rats studied 1-2 weeks after recovery, except that the conduction velocity tended to be higher in the former group ( Fig. 1C ; Table 1 ). In 1 rat from the group studied early after recovery and in 1 rat from the group studied late after recovery the conduction velocity was more than 3 SD below the normal mean, indicating slowing of conduction. These findings indicate restoration of conduction in the sacral ventral roots during clinical recovery from acute MBP-EAE. 
TABLE 1. Maximal S-2 ventral root compound action potential evoked by stimulation of the ventral caudal trunk
In this and the subsequent tables, the data from normal controls and from rats with neurological signs of MBP-EAE have been reported previously by Chalk at al.
2 P values calculated using ANOVA with Sonferroni correction for multiple comparisons. P c = P value calculated in comparison with normal controls; P n = P value calculated in comparison with rats with neurological signs of MBP-EAE; P e = P value calculated in comparison with rats 1-2 weeks after recovery from the neurological signs of MBP-EAE. * Conduction distance measured in only 7 rats with neurological signs of MBP-EAE.
S-2 Dorsal Root
Recordings. The normal S-2 dorsal root response evoked by stimulation of the ventral caudal trunk consists of a biphasic wave (positive, negative) ( Fig. 2A ; Table 2 ). In rats with neurological signs of MBP-EAE the mean peak-to-peak amplitude of the maximal dorsal root compound action potential is markedly less than that of normal controls, and the mean conduction velocity of the peak of the negativity is less than that in normal controls, but not significantly ( Fig. 2B ; Table 2 ). As there is no temporal dispersion, the reduction in the amplitude of the dorsal root response indicates conduction block in a high proportion of the afferent fibers between the ventral caudal trunk and the proximal dorsal root. In rats studied 1-2 weeks after clinical recovery the mean peak-to-peak amplitude was significantly increased when compared to the corresponding value in rats with neurological signs of MBP-EAE and was not significantly different from that in normal controls ( Table 2 ). The mean conduction velocity of the peak of the negativity was increased, but not significantly, when compared with rats with neurological signs of MBP-EAE, and was not significantly different from that in normal controls. The results in rats studied 4 weeks after clinical recovery were similar to those in rats studied 1-2 weeks after recovery ( Fig. 2C ; Table 2 ). In 2 rats from the group studied late after recovery, the conduction velocity was more than 3 SD below the normal mean, indicating slowing of conduction.
These results indicate restoration of conduction in the peripheral afferent pathway during clinical recovery from MBP-EAE.
TABLE 2. Maximal S-2 dorsal root compound action potential evoked by stimulation of the ventral caudal trunk
P values calculated by using ANOVA with Bonferroni correction for multiple comparisons. P c = P value calculated in comparison with normal controls; P n = P value calculated in comparison with rats with neurological signs of MBP-EAE: P e = P value calculated in comparison with rats 1-2 weeks after recovery from the neurological signs of MBP-EAE. *Conduction distance measured in only 6 normal controls and 7 rats with neurological signs of MBP-EAE.
S-2 DREZ Recordings.
The normal S-2 DREZ response evoked by stimulation of the ventral caudal trunk consists of the biphasic (positive, negative) afferent volley potential followed by the N wave, a field potential due to synaptic currents in second order neurons in the dorsal horn excited mainly by low-threshold cutaneous afferents ( Fig. 3A; Table 3 ). In rats with neurological signs of MBP-EAE, the mean peak-to-peak amplitude of the maximal afferent volley potential, the mean conduction velocity of the peak of negativity of the afferent volley potential, and the mean amplitude of the maximal N wave peak are all significantly reduced compared with the findings in normal controls, and the mean latency to the peak of the N wave is increased significantly (Fig. 3B; Table 3 ). These abnormalities can be mainly explained by the conduction abnormalities in the peripheral afferent pathway detected in the S-2 dorsal root recordings (see above) but conduction abnormalities between the dorsal root and DREZ recording sites may also contribute.
In rats studied 1-2 weeks after clinical recovery the mean peak-to-peak amplitude of the maximal afferent volley potential was significantly higher than that in rats with neurological signs of MBPEAE and was not significantly different from that in normal controls ( Fig. 3C; Table 3 ). The mean velocity of the afferent volley potential was higher than that in rats with neurological signs of MBPEAE but the differences were not statistically significant. The mean amplitude of the peak of the N wave was higher than that in rats with neurological signs but not significantly; it was similar to that in normal controls. The mean latency to the peak of the N wave was shorter than that in rats with neurological signs, although not significantly, and was similar to that in normal controls. The results in rats studied 4 weeks after clinical recovery were similar to those in rats studied 1-2 weeks after recovery, except that the conduction velocity of the afferent volley potential tended to be higher in the latter (Table 3 ). In I rat from the group studied early after recovery and in 1 rat from the group studied late after recovery the conduction velocity was more than 3 SD below the normal mean, indicating slowing of conduction. These results also indicate restoration of conduction in the peripheral afferent pathway during clinical recovery from MBP-EAE. Dorsal Column Recordings. The normal lumbosacral dorsal column compound action potential consists of a biphasic wave (positive, negative) ( Figure 4A ; Table 4 ). In rats with neurological signs of MBP-EAE, there is a marked reduction in the mean peak-to-peak amplitude of the maximal dorsal column compound action potential compared to that in normal controls, and the latency to the peak of the negativity is longer than in normal controls, but not significantly ( Fig. 4B; Table 4 ). As there is no temporal dispersion, the reduction in amplitude indicates conduction block in a high proportion of the dorsal column fibers. Repetitive supramaximal dorsal column stimulation (10 Hz for 60 s), which may reveal the impaired ability of demyelinated fibers to transmit trains of impulses, 7 causes a mean amplitude increase of 0.7 ± 6.0% in rats with neurological signs of MBP-EAE (n = 4), which is not significantly different from the effect in normal controls (3.8 ± 2.5%; n = 5).
TABLE 3. Maximal S-2 dorsal root entry zone response evoked by stimulation of the ventral caudal trunk
P values calculated using ANOVA with Bonferroni correction for multiple comparisons. P c = P value calculated in comparison with normal controls; P n = P value calculated in comparison with rats with neurological signs of MBP-EAE; P e = P value calculated in comparison with rats 1-2 weeks after recovery from the neurological signs of MBP-EAE. *Conduction distance measured in only 9 normal controls and 7 rats with neurological signs of MBP-EAE. In rats studied 1-2 weeks after recovery, the mean peak-to-peak amplitude of the maximal dorsal column compound action potential was similar to that in rats with neurological signs of MBP-EAE and markedly less than that in normal controls ( Fig. 4C ; Table 4 ). The mean latency to the peak of the negativity was significantly increased in these rats compared to that in normal controls, and was also increased compared to that in rats with neurological signs of MBP-EAE, but the latter difference was not statistically significant. In rats studied 4 weeks after recovery, the mean peak-to-peak amplitude was significantly higher than in rats with neurological signs of MBP-EAE and was not significantly different from that in normal controls (Fig. 4D) . It was also higher than that in rats studied 1-2 weeks after recovery, although the difference was not statistically significant. The mean latency to the peak of the negativity in rats studied 4 weeks after recovery was increased compared to that in normal controls and to that in rats with neurological signs, but the differences were not significant. It was less than that in rats studied 1-2 weeks after recovery although the difference was not significant. These findings indicate that restoration of conduction in the dorsal columns occurs relatively late after clinical recovery from MBP-EAE. As shown in Figure 4D , there was some temporal dispersion of the dorsal column compound action potential in 2 of the 5 rats studied 4 weeks after clinical recovery, indicating slowing of conduction in some fibers. In these 2 rats the duration of the negativity was more than 3 SD greater than the mean in normal controls (817 ± 86 µs, n = 5). To assess for impaired ability to transmit trains of impulses in late recovery from MBP-EAE, the effect of repetitive supramaximal dorsal column stimulation (10 Hz for 60 s) was examined in 2 rats. This resulted in a mean amplitude decrease of 14.1 ± 0.3%, which was significantly different from the effect in normal controls (see above); these effects were reversible when stimulation at 0.3 Hz was resumed after a period of no stimulation. The effects of repetitive stimulation suggest that conduction in some fibers is insecure 4 weeks after clinical recovery.
TABLE 4. Maximal lumbosacral dorsal column compound action potential
P values calculated using ANOVA with Bonferroni correction for multiple comparisons. P c = P value calculated in comparison with normal controls; P n = P value calculated in comparison with rats with neurological signs of MBP-EAE; P e = P value calculated in comparison with rats 1-2 weeks after recovery from the neurological signs of MBP-EAE. *Response absent in 4 rats.
DISCUSSION
In the present study, we have made the new finding that restoration of conduction in the spinal roots correlates with clinical recovery from acute MBP-EAE in the Lewis rat. We have previously demonstrated primary demyelination and evidence of nerve conduction block in the spinal roots of the PNS, and in the ventral root exit zones and dorsal columns of the CNS of rats with neurological signs of this form of EAE. 2, 12 In the present study, we found that 1-2 weeks after recovery from tail weakness there was resolution of conduction block in the sacral dorsal and ventral roots but persistent severe conduction block in the dorsal columns. Four weeks after clinical recovery, conduction was restored in the dorsal columns although there was evidence of conduction slowing and insecure conduction in some fibers. Restoration of conduction in the spinal roots would contribute to the restoration of transmission through the lumbar monosynaptic reflex arc that we have previously demonstrated during recovery from acute MBP-EAE. 13 The restoration of conduction in the PNS and the CNS can be accounted for by remyelination by Schwann cells and oligodendrocytes, respectively. We have previously shown compact myelin formation by Schwann cells in the PNS and by oligodendrocytes in the CNS 5 and 6 days, respectively, after the onset of neurological signs of acute EAE in the Lewis rat. 13, 14 The later recovery of function in the dorsal columns than in the spinal roots is most likely due to a slower rate of remyelination in the dorsal columns. Studies in non-inflammatory models of demyelination have shown a slower rate of recovery of conduction in the dorsal columns 19 than in the PNS 20 although these studies were performed in different species (cat and rat, respectively).
Our present finding of restoration of conduction in the spinal roots at the time of clinical recovery extends our previous studies on rats during the clinical phase and supports our previous conclusion that PNS conduction block due to a demyelinating polyradiculitis is a major cause of neurological signs of acute MBP-EAE in the Lewis rat. 11, 12 Conduction block due to demyelination of the CNS portion of the ventral root exit zone of the spinal cord may also contribute to the weakness. 12 As conduction through descending motor pathways in the brainstem and spinal cord was not assessed in the present study, it is not possible to exclude a contribution to the weakness by involvement of these pathways. We suggest that the prominent abnormalities of the proximal PNS in MBP-EAE may have implications for the human inflammatory demyelinating diseases, namely acute disseminated encephalomyelitis and multiple sclerosis, in which MBP is a putative target antigen.
